NexThera Completes First Patient Enrollment in U.S. Clinical Trial for ‘NT-101,’ an Eye Drop Treatment for Wet AMD

BUSAN, South Korea--(BUSINESS WIRE)-- #BiopharmaceuticalCompany--NexThera completed the initial patient enrollment for its Phase 1/2a clinical trial of NT-101, a novel eye drop treatment for wet AMD.